scispace - formally typeset
T

T. Xu

Researcher at National Institutes of Health

Publications -  5
Citations -  1213

T. Xu is an academic researcher from National Institutes of Health. The author has contributed to research in topics: Biglycan & Growth factor. The author has an hindex of 5, co-authored 5 publications receiving 1156 citations.

Papers
More filters
Journal ArticleDOI

Targeted disruption of the biglycan gene leads to an osteoporosis-like phenotype in mice

TL;DR: This is the first report in which deficiency of a non-collagenous ECM protein leads to a skeletal phenotype that is marked by low bone mass that becomes more obvious with age and may serve as an animal model to study the role of ECM proteins in osteoporosis.
Journal ArticleDOI

Phenotypic effects of biglycan deficiency are linked to collagen fibril abnormalities, are synergized by decorin deficiency, and mimic Ehlers-Danlos-like changes in bone and other connective tissues.

TL;DR: It is reported that bgn deficiency leads to structural abnormality in collagen fibrils in bone, dermis, and tendon, and to a “subclinical” cutaneous phenotype with thinning of the dermis but without overt skin fragility.
Journal ArticleDOI

Age-related osteoporosis in biglycan-deficient mice is related to defects in bone marrow stromal cells.

TL;DR: The combination of decreased proliferation and increased apoptosis would lead to a deficiency in the generation of mature osteoblasts and would be sufficient to account for the osteopenia developed in the bgn KO mice.
Journal Article

Small leucine-rich proteoglycans in the aging skeleton.

TL;DR: This review outlines the novel research findings uncovered using these new animal models to examine SLRP function, and examines them at the tissue, cell and molecular levels.
Journal ArticleDOI

Immortalization and Characterization of Bone Marrow Stromal Fibroblasts from a Patient with a Loss of Function Mutation in the Estrogen Receptor-α Gene

TL;DR: These lines of HERKO cells retain several of the phenotypic traits of MSFs after immortalization, including matrix and cytokine production, and provide a valuable source of a unique human material for future studies involving estrogen action in bone and bone marrow metabolism.